Finding Hope After An Advanced Prostate Cancer Diagnosis
- A diagnosis of metastatic prostate cancer can feel overwhelming. Still, there’s growing hope thanks to new and evolving treatments that can make the cancer manageable and treated more like a chronic disease.
- “Although it’s a disease we can’t get rid of…it’s a disease that we control much better today than we controlled five or 10 years ago,” Dr. Vivek Narayan, a medical oncologist at the University of Pennsylvania, tells SurvivorNet.
- Combination therapy is a key approach in treating metastatic prostate cancer, helping slow disease progression and improve quality of life.
- These treatments give patients the opportunity to live longer and more fulfilling lives, even with an advanced diagnosis.
He emphasizes that metastatic prostate cancer is no longer a short-term prognosis for many patients. Thanks to modern therapies, outcomes have dramatically improved.
Read MoreAdvancements In Care Offer Hope
Dr. Narayan is part of a growing movement in oncology that embraces combination therapy as the backbone of metastatic prostate cancer treatment. This approach pairs traditional hormone therapy (also called androgen deprivation therapy or ADT) with FDA-approved oral agents like abiraterone, enzalutamide, apalutamide, and darolutamide — each designed to disrupt the testosterone-driven growth of cancer cells further. These therapies not only slow disease progression but also offer patients a chance at living longer, fuller lives — even with an advanced diagnosis.Living Longer, Living Well
Dr. Narayan highlights the progress in advanced prostate cancer care, noting that the disease is increasingly manageable and patients now have greater potential for improved quality of life. Still, patients must be carefully monitored.
“Even with metastatic prostate cancer, it’s not always the cancer that causes the biggest problems. We’ve got to keep an eye on overall health, because that matters just as much.” Dr. Narayan notes.
This shift in perspective is critical — not just for patients, but for caregivers and clinicians alike. It reframes the diagnosis from a terminal sentence to a chronic condition that can be managed with precision and care.
The outlook for prostate cancer care is promising, driven by breakthroughs in treatment and the rise of personalized medicine. Dr. Narayan’s work at Penn Medicine, among other cancer research centers across the country, continues to push the boundaries of what’s possible, offering patients not just treatment but a renewed sense of continued hope.
Questions To Ask Your Doctor
- What new approaches to treatment are available to me?
- Should I be treated with combination therapies?
- Does combining treatments increase my risk of side effects?
- How often will I be monitored?
Learn more about SurvivorNet's rigorous medical review process.
